Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.120
-0.160 (-12.50%)
At close: Sep 26, 2025, 4:00 PM EDT
1.120
0.00 (-0.01%)
After-hours: Sep 26, 2025, 7:49 PM EDT
Company Description
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally.
The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform.
The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022.
Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
Intelligent Bio Solutions Inc.
| Country | United States |
| Founded | 2016 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 55 |
| CEO | Harry Simeonidis |
Contact Details
Address: 135 West, 41st Street, 5th Floor New York, New York 10036 United States | |
| Phone | 646 828 8258 |
| Website | ibs.inc |
Stock Details
| Ticker Symbol | INBS |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001725430 |
| CUSIP Number | 36151G600 |
| ISIN Number | US36151G6008 |
| Employer ID | 82-1512711 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Harry Simeonidis | President and Chief Executive Officer |
| Spiro Kevin Sakiris B.Bus, C.A., CA, Dip Law | Chief Financial Officer |
| Callistus Sequeira | Vice President of Global Quality and Operations |
| Doug Heath | Vice President of Global Sales |
| Anna Turkington | Vice President of Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 26, 2025 | 8-K | Current Report |
| Sep 25, 2025 | 8-K | Current Report |
| Sep 19, 2025 | ARS | Filing |
| Sep 19, 2025 | DEF 14A | Other definitive proxy statements |
| Sep 18, 2025 | 424B5 | Filing |
| Sep 17, 2025 | 8-K | Current Report |
| Sep 15, 2025 | 424B3 | Prospectus |
| Sep 11, 2025 | 424B3 | Prospectus |
| Sep 10, 2025 | EFFECT | Notice of Effectiveness |
| Sep 9, 2025 | EFFECT | Notice of Effectiveness |